Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 5/20 | 0.58 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.58 |
| ▸ | RXRA | P19793 | 1/20 | 0.53 |
| ▸ | RXRB | P28702 | 1/20 | 0.53 |
| ▸ | RXRG | P48443 | 1/20 | 0.53 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP14 | P50281 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.46 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.46 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.46 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27481094 | 0.88 | MEN1 (0.54) | PARP10PARP15RXRARXRBRXRG | |
| SCHEMBL6854366 | 0.88 | PARP10 (0.50) | PARP10PARP15SRD5A2MMP2MMP14 | |
| SCHEMBL8373636 | 0.86 | MMP2 (0.56) | PARP10PARP15RXRARXRBRXRG | |
| SCHEMBL6894961 | 0.86 | SRD5A2 (0.47) | PARP10PARP15RXRARXRBRXRG | |
| SCHEMBL9251374 | 0.86 | PARP10 (0.58) | PARP10PARP15RXRARXRBRXRG | |
| SCHEMBL10883326 | 0.86 | NR4A1 (0.63) | PARP10PARP15RXRARXRBRXRG | |
| SCHEMBL19809245 | 0.85 | NR4A1 (0.58) | PARP10MMP2MMP14ALDH1A1KMT2A | |
| SCHEMBL716944 | 0.85 | NR4A1 (0.58) | PARP10MMP2MMP14ALDH1A1KMT2A | |
| SCHEMBL7658168 | 0.84 | HPGD (0.50) | PARP10PARP15RXRARXRBRXRG | |
| SCHEMBL436522 | 0.83 | NR4A1 (0.61) | PARP10MMP2MMP14ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6437178-B2 | REACTING A HALOGENATED BENZENE COMPOUND WITH NITRO(THIO)PHENOL; REDUCTION | INFINEON TECHNOLOGIES AG (DE) | 2002-08-20 | — | — | US | disclosed |
| US-20010056203-A1 | O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid | SIEMENS AKTIENGESELLSCHAFT | 2001-12-27 | — | — | US | disclosed |
| EP-0905123-B1 | o-amino(thio)phenol-carboxylic acids and their preparation | INFINEON TECHNOLOGIES AG (DE) | 2001-12-12 | — | — | EP | disclosed |
| US-6310238-B1 | INTERMEDIATES FOR THE PREPARATION OF POLYBENZOXAZOLES AND POLYBENZOTHIAZOLES | SIEMENS AKTIENGESELLSCHAFT (DE) | 2001-10-30 | — | — | US | disclosed |
| EP-0905123-A1 | o-amino(thio)phenol-carboxylic acids and their preparation | SIEMENS AKTIENGESELLSCHAFT (DE) | 1999-03-31 | — | — | EP | disclosed |
| EP-0905170-A2 | Polybenzoxazoles and polybenzothiazoles precursors | SIEMENS AKTIENGESELLSCHAFT (DE) | 1999-03-31 | — | — | EP | disclosed |
| EP-0291778-B1 | Process for the preparation of high temperature-resistant dielectrics | SIEMENS AG (DE) | 1994-03-16 | — | — | EP | disclosed |
| US-4965134-A | Method for manufacturing highly heat-resistant dielectrics | SIEMENS AKTIENGESELLSCHAFT (DE) | 1990-10-23 | — | — | US | disclosed |
| EP-0291778-A1 | Process for the preparation of high temperature-resistant dielectrics | SIEMENS AKTIENGESELLSCHAFT (DE) | 1988-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056203-A1 | O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid | TPMT, PAH, AADAT | PARP10 4292/4885PARP15 3895/4885RXRA 782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.